Delivery Order SPE2DB24D2101-SPE2DB25FKNKN
- Not listed
- The Defense Logistics Agency awarded a $348,330 firm fixed price delivery order to Amerisourcebergen Drug Corporation for AJOVY 225 MG/1.5 ML autoinjectors. The single-award contract supports DLA's medical supply needs and calls for Amerisourcebergen to deliver 1.5mL autoinjectors of AJOVY, a medication used to prevent migraines, to a location in Conshohocken, Pennsylvania by July 14, 2023. No subcontractors or set-aside designations were identified. The delivery order was issued against an...
- The Defense Logistics Agency awarded a $348 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 1.5ml autoinjectors of AJOVY 225mg to be delivered to a location in Conshohocken, Pennsylvania within a one day period from August 1st through August 2nd, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for migraine treatment devices supports the Agency's mission to provide critical health resources and enhances...
- The Defense Logistics Agency awarded a $200,050 firm fixed price delivery order to Amerisourcebergen Drug Corporation for AJOVY 225 MG/1.5 ML autoinjectors. The prime contractor will provide 1.5mL autoinjectors of AJOVY, a medication used to prevent migraines, for use by the Department of Defense. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from August 16-17, 2023. No set aside designation or subcontractors were identified....
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at three hundred forty-eight thousand three hundred thirty-two dollars ($348,332) to Amerisourcebergen Drug Corporation for the supply of two hundred twenty-five milligrams per one and a half milliliters doses of AJOVY autoinjectors. Performance will take place at Amerisourcebergen's facility located in Conshohocken, Pennsylvania from September 18 through September 19, 2023. The award was made using the Defense...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 11, 2025, for the supply of AJOVY 225 mg/1.5 ml auto-injector units. The contract carries a ceiling value of $7,564.38 and is structured as a firm fixed-price delivery order with an ultimate completion date of August 12, 2025. This award represents a non-set-aside competitive procurement and is performed at the vendor's corporate office location...
- The Defense Logistics Agency awarded a $348,330 firm fixed price delivery order to Amerisourcebergen Drug Corporation for AJOVY 225 MG/1.5 ML syringes. The single award was issued under an undisclosed government-wide acquisition contract vehicle or blanket purchase agreement held by Amerisourcebergen. Performance will occur at the prime contractor's facility in Conshohocken, Pennsylvania with delivery required by August 21, 2023 to support DLA programs. No set aside designation or subcontractors...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at three hundred forty-eight dollars and thirty-three cents ($348.33) to Amerisourcebergen Drug Corporation for AJOVY 225 MG/1.5 ML autoinjectors to be delivered to a facility located in Conshohocken, Pennsylvania. As a pharmaceutical distributor, Amerisourcebergen will supply the Defense Logistics Agency with 1.5mL autoinjectors of AJOVY, a medication used to prevent migraines, to support the Agency's medical...
- The Defense Logistics Agency awarded a $4,554.55 delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of AJOVY 225 mg/1.5 mL auto-injector units. The contract is classified as a firm fixed price delivery order with an ultimate completion date of August 4, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award utilized no set-aside provisions, reflecting the competitive nature of the procurement. AmerisourceBergen Drug Corp, a...
- Defense Logistics Agency Troop Support Medical awarded a $696 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of AJOVY 225MG/1.5ML prefilled syringes. The contract has no set-aside designation and requires performance at the awardee's location in Conshohocken, Pennsylvania, with all work to be completed by October 23, 2023. As the Defense Logistics Agency supports the healthcare needs of military members,...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,189.39 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of the specialty medication AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML. This contract, which does not have a set-aside designation, has an ultimate completion date of December 10, 2024. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, is the prime contractor for this award. The company maintains significant Indefinite...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKNKNDelivery Order
The Defense Logistics Agency awarded a $4,376.49 delivery order to AmerisourceBergen Drug Corp for AJOVY (fremanezumab) 225 mg/1.5 mL auto-injector auto-injectors, with delivery to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 14, 2025. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $1 billion and extends through December 2026, serving as a comprehensive pharmaceutical support vehicle for military healthcare programs worldwide. AJOVY is a monoclonal antibody treatment for migraine prevention used within military and veteran healthcare systems. This delivery order represents routine pharmaceutical procurement through the DLA's established supply chain for the Defense Health Agency and other federal healthcare entities. AmerisourceBergen's significant federal pharmaceutical portfolio and competitive standing with the DLA reflect its critical role as a major supplier of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military medical operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 8/13/25 |